ENGLEWOOD, Colo., May 10, 2022
/PRNewswire/ -- Zynex, Inc. (Nasdaq: ZYXI), an innovative
medical technology company specializing in the manufacture and sale
of non-invasive medical devices for pain management,
rehabilitation, and patient monitoring, today announced that it
will participate in two upcoming investor conferences.
Zynex management will be participating virtually in the H.C.
Wainwright Annual Global Investment Conference. Interested parties
can access the live and archived webcast on the Events section of
the website
at https://zynexmed.investorroom.com/ir-home on
Tuesday, May 24, 2022, at
7am ET.
Zynex management is also scheduled to present at the UBS Global
Healthcare Conference on Wednesday, May 25,
2022, at 12:15 PM ET.
Interested parties can access the live and archived webcast at
https://zynexmed.investorroom.com/ir-home.
About Zynex, Inc.
Zynex, founded in 1996,
develops, manufactures, markets, and sells medical devices used for
pain management and rehabilitation as well as non-invasive fluid,
sepsis and laser-based pulse oximetry monitoring
systems for use in hospitals. For additional information, please
visit: www.zynex.com
Investor Contact
Gilmartin Group
650
Fifth Ave., Suite 2720
New York, NY 10019
IR@zynex.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/zynex-medical-to-participate-in-upcoming-investor-conferences-301543538.html
SOURCE Zynex